Cognate acquires Cobra Biologics

Cognate BioServices has acquired UK and Sweden-based Cobra Biologics, an advanced therapy CDMO that specializes in providing manufacturing services for the plasmid DNA and viral vector. No financial terms were disclosed. Cognate's backers include EW Healthcare Partners.

DealsNorth AmericaUSHealthcareBriefs